跳至主要内容
临床试验/NCT02859090
NCT02859090已完成不适用

Single-centre Study of the Expression of Heat Shock Proteins in the Lymphocytes From the Tonsils of Patients With Various Diseases Requiring Tonsillectomy

Centre Hospitalier Universitaire Dijon2 个研究点 分布在 1 个国家目标入组 5 人开始时间: 2014年8月26日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
5
试验地点
2
主要终点
expression of heat shock proteins

研究概览

简要总结

It has recently been shown that various HSPs are strongly expressed in B lymphomas. Indeed, HSP90 stabilizes the protein Bcl-6 in diffuse large-cell B lymphomas. Pharmacological inhibition of HSP90 in vitro induced apoptosis in lymphoma cells (Cerchietti et al. Nat. Medicine, 2009, 1369-1376). In addition, HSP110 is strongly expressed in non-Hodgkin lymphomas, and targeting this HSP at the cell surface using specific antibodies could constitute a future therapy (Zappasodi et al. Blood, 2011, 4421-4430). Despite the importance of these proteins in the development of lymphomas, their expression and their role in the activation of normal B lymphocytes and the normal development of germinal centres is not known.

The expression of Heat shock proteins should vary among the different B lymphocyte populations present in the tonsils (naïve B cells, memory B cells, germinal centre B cells).

The aim of this study is to establish an expression profile for heat shock proteins in populations of B lymphocytes in human tonsils

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • Persons who have provided oral consent
  • Tonsillectomy in children or adults

排除标准

  • Persons without national health insurance cover
  • Adults under guardianship
  • Pregnant or breast-feeding women
  • Persons with positive HIV or HCV serology

研究组 & 干预措施

patient

Experimental

干预措施: tonsillectomy (Procedure)

patient

Experimental

干预措施: blood sample (Biological)

结局指标

主要结局

expression of heat shock proteins

时间窗: Day one

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验